.Takeda has actually stopped (PDF) a stage 2 trial of danavorexton due to slow application, denoting...
.Compass Pathways' journey to stage 3 psychedelic anxiety records is actually taking much longer tha...
.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2015 for a monstrous $43...
.On the heels of a phase 3 gain that stopped working to blow away capitalists, Ironwood Pharmaceutic...
.Don't stop Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball af...
.Invite to recently's Chutes & Ladders, our roundup of substantial management hirings, firings an...
.Commemorating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey F...
.AbbVie has returned to the resource of its own antipsychotic powerhouse Vraylar in search of an add...
.GenSight Biologics is actually full weeks away from losing cash. Again. The biotech merely has enou...
.Monopar Therapies is recuperating a drug coming from the scrap heap of AstraZeneca's unusual health...